Picture this: Five years ago, Stryker $SYK stock traded near $241 per share. Today in March 2026, it closes at $335.67 — a steady +39% gain. The chart shows a clear recovery from earlier dips, with consistent upward movement in recent years tied to demand for orthopedic implants, surgical tools, and hospital equipment.

The 52-week high reached $404.87, showing the stock has already climbed much higher during stronger periods.

Keeping it simple: The compound annual growth rate (CAGR) over these five years is about 6.9%. If this pace holds, it means dependable yearly progress that builds gradually through compounding.

Now picture using dollar-cost averaging (DCA): adding $500 every month for the next five years. This totals $30,000 invested from your pocket over 60 months. You naturally buy more shares on lower price days and fewer on higher ones, which helps keep your average cost balanced.

Build your portfolio, one day at a time.
Get our daily 5-year horizon picks sent to your inbox. Subscribe here.

If SYK continues at a similar historical pace around 6.9% annual growth, your monthly $500 contributions could grow your investment to about $36,200 by the end of five years. That means a gain of roughly $6,200 beyond what you put in — a solid 21% overall return from patient, regular investing.

Past performance doesn't guarantee the future — healthcare spending, competition, or economic changes can affect results. But SYK stays a strong leader in medical technology with good exposure to aging populations and surgical needs. Your $500 monthly plan is straightforward to keep up, letting time do the work quietly.

The ongoing demand for better medical devices keeps supporting this sector over the long run. Staying consistent through any slower stretches is what usually delivers steady long-term results.

Ready to follow this reliable path?